Suppr超能文献

与癌胚抗原相比,人绒毛膜促性腺激素在鉴别良性与恶性胸腔积液中的价值。

Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions.

作者信息

Lamerz R, Stoetzer O J, Mezger J, Brandt A, Darsow M, Wilmanns W

机构信息

Medical Department II, Klinikum Grosshadern, University of Munich, Germany.

出版信息

Anticancer Res. 1999 Jul-Aug;19(4A):2421-5.

Abstract

Human chorionic gonadotropin (HCG) is expressed in germ cell tumors and urothelial, breast, lung and colon cancers. The aim of the study was to investigate if the determination of HCG in comparison with CEA is able to discriminate between malignant and benign effusions. Effusion and partially serum samples of 61 patients with benign (g.i., heart/kidney isnuff.) and 116 patients with malignant diseases (g.i., gynec., lung, misc., CUP) were investigated. HCG was specifically determined by an IRMA using 2 monoclonal antibodies, CEA by a conventional double Ab RIA. Cytological staining was preformed using the Pappenheim-method on cytospin preparations. Significant differences (p < 0.001) were found for HCG between benign and malignant ascitic effusions with the best discrimination at 5 IU/l (ROC) and an overall sensitivity of 31.3% (spec. vs benign eff. 93.4%) increasing in subgroups from hematol. (5.8%) < misc. (31.3%) < gynec. (32.1%) < g.i. (36%) < lung (38.1%) to CUP (50%). CEA also showed significant differences between benign and malignant total and ascitic effusions, and weaker for the pleural subgroup (cutoff 9 ng/ml) with a total sensitivity of 44.6% (sp = 100%) increasing from misc. (30.8%) < lung (47.1%) < CUP (50%) < gynec. (60%) < g.i. (60.9%). Comparative cytology and TM determinations increased the positiverate of cytology (45.2%) to 58.3% for either cytology or HCG positive cases, or to 61.6% for either cytology or CEA positive cases. For the combined determination of cytologoy and HCG and CEA, the overall TM positive rate for 33 cytology-pos. cases was 78.8%, but in 40 cytology-negative cases 37.5% for TM positive cases. In conclusion HCG is useful in ascitic > pleural effusions with high specificity (90% at 5 IU/l) but low sensitivity of 31% increasing in g.i., lung and gynecologic cases, CEA a more general TM with higher sensitivity of 45% increasing in g.i., gynecologic and lung cases (sp. 100% at 9 ng/ml) both adding significantly to cytology-negative effusions.

摘要

人绒毛膜促性腺激素(HCG)在生殖细胞肿瘤以及尿路上皮癌、乳腺癌、肺癌和结肠癌中均有表达。本研究的目的是调查与癌胚抗原(CEA)相比,检测HCG是否能够区分恶性和良性积液。对61例患有良性疾病(胃肠道、心脏/肾脏疾病)的患者和116例患有恶性疾病(胃肠道、妇科、肺部、其他、不明原发部位癌)的患者的积液及部分血清样本进行了研究。采用使用2种单克隆抗体的免疫放射分析(IRMA)法特异性检测HCG,采用传统双抗体放射免疫分析(RIA)法检测CEA。在细胞离心涂片上采用帕彭海姆法进行细胞学染色。发现良性和恶性腹水积液中的HCG存在显著差异(p < 0.001),在5 IU/l时鉴别效果最佳(ROC),总体敏感性为31.3%(与良性积液相比特异性为93.4%),在各亚组中敏感性递增,依次为血液科(5.8%)<其他(31.3%)<妇科(32.1%)<胃肠道(36%)<肺部(38.1%)<不明原发部位癌(50%)。CEA在良性和恶性的总积液及腹水积液中也显示出显著差异,在胸腔积液亚组中差异较弱(临界值9 ng/ml),总体敏感性为44.6%(特异性 = 100%),敏感性递增依次为其他(30.8%)<肺部(47.1%)<不明原发部位癌(50%)<妇科(60%)<胃肠道(60.9%)。比较细胞学检查和肿瘤标志物(TM)检测可将细胞学检查的阳性率(45.2%)提高到58.3%(针对细胞学检查或HCG阳性的病例),或提高到61.6%(针对细胞学检查或CEA阳性的病例)。对于细胞学检查与HCG和CEA的联合检测,33例细胞学检查阳性病例的总体TM阳性率为78.8%,但在40例细胞学检查阴性病例中TM阳性病例的比例为37.5%。总之,HCG对腹水>胸腔积液有用,具有高特异性(5 IU/l时为90%)但低敏感性,为31%,在胃肠道、肺部和妇科病例中敏感性递增;CEA是一种更通用的TM,敏感性较高,为45%,在胃肠道、妇科和肺部病例中敏感性递增(9 ng/ml时特异性为100%),二者对细胞学检查阴性的积液均有显著补充作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验